BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19936915)

  • 1. A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.
    Wang W; Rayburn ER; Velu SE; Chen D; Nadkarni DH; Murugesan S; Chen D; Zhang R
    Breast Cancer Res Treat; 2010 Sep; 123(2):321-31. PubMed ID: 19936915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
    Wang W; Rayburn ER; Velu SE; Nadkarni DH; Murugesan S; Zhang R
    Clin Cancer Res; 2009 May; 15(10):3511-8. PubMed ID: 19451594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
    Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
    Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
    Chen T; Xu Y; Guo H; Liu Y; Hu P; Yang X; Li X; Ge S; Velu SE; Nadkarni DH; Wang W; Zhang R; Wang H
    PLoS One; 2011; 6(6):e20729. PubMed ID: 21673964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog.
    Zhang X; Xu H; Zhang X; Voruganti S; Murugesan S; Nadkarni DH; Velu SE; Wang MH; Wang W; Zhang R
    Mar Drugs; 2012 May; 10(5):1138-1155. PubMed ID: 22822362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.
    Ezell SJ; Li H; Xu H; Zhang X; Gurpinar E; Zhang X; Rayburn ER; Sommers CI; Yang X; Velu SE; Wang W; Zhang R
    Mar Drugs; 2010 Jul; 8(7):2129-41. PubMed ID: 20714427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.
    Wang F; Ezell SJ; Zhang Y; Wang W; Rayburn ER; Nadkarni DH; Murugesan S; Velu SE; Zhang R
    Invest New Drugs; 2010 Jun; 28(3):234-41. PubMed ID: 19274441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism.
    Jiang Y; Fan L
    J Ethnopharmacol; 2020 Jul; 257():112851. PubMed ID: 32283190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine induces the apoptosis of breast cancer cells by regulating apoptosis-related proteins of mitochondria.
    Zhang X; Lu H; Wang Y; Liu C; Zhu W; Zheng S; Wan F
    Int J Mol Med; 2015 Jan; 35(1):218-26. PubMed ID: 25395275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
    Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model.
    Ottewell PD; Lefley DV; Cross SS; Evans CA; Coleman RE; Holen I
    Int J Cancer; 2010 Jan; 126(2):522-32. PubMed ID: 19621384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo.
    Lv ZD; Liu XP; Zhao WJ; Dong Q; Li FN; Wang HB; Kong B
    Int J Clin Exp Pathol; 2014; 7(6):2818-24. PubMed ID: 25031701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.
    De Santi M; Galluzzi L; Lucarini S; Paoletti MF; Fraternale A; Duranti A; De Marco C; Fanelli M; Zaffaroni N; Brandi G; Magnani M
    Breast Cancer Res; 2011 Mar; 13(2):R33. PubMed ID: 21435243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VALD-3, a Schiff base ligand synthesized from o-vanillin derivatives, induces cell cycle arrest and apoptosis in breast cancer cells by inhibiting the Wnt/β-catenin pathway.
    Li H; Dang C; Tai X; Xue L; Meng Y; Ma S; Zhang J
    Sci Rep; 2021 Jul; 11(1):14985. PubMed ID: 34294779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.
    Niwa AM; D Epiro GF; Marques LA; Semprebon SC; Sartori D; Ribeiro LR; Mantovani MS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):557-71. PubMed ID: 26932586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
    Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
    Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway.
    Jedinak A; Sliva D
    Int J Oncol; 2008 Dec; 33(6):1307-13. PubMed ID: 19020765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.